Patents by Inventor Barry A Murrer

Barry A Murrer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising metal complexes
    Patent number: 6417182
    Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localized high concentration of nitric oxide in the body.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: July 9, 2002
    Assignee: AnorMED Inc.
    Inventors: Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
  • Pharmaceutical compositions comprising metal complexes
    Patent number: 6284752
    Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localised high concentration of nitric oxide in the body.
    Type: Grant
    Filed: October 19, 1998
    Date of Patent: September 4, 2001
    Assignee: AnorMED Inc.
    Inventors: Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
  • Chemical compounds
    Patent number: 6001826
    Abstract: Pharmaceutical compositions containing as active ingredients a linked cyclic compound of the general formula IZ--(A).sub.n --Y (I)in which Z and Y are independently cyclic polyamine moieties having from 9 to 32 ring members and from 3 to 8 amine nitrogen atoms in the ring, A is a linking atom or group, and n is O or an integer from 1 to 6, are indicated for the treatment of viral infections, and preventative administration, especially for retroviral infections.
    Type: Grant
    Filed: July 20, 1992
    Date of Patent: December 14, 1999
    Assignee: AnorMed, Inc.
    Inventors: Barry A Murrer, David A Schwartz
  • Pharmaceutical composition containing selected lanthanum carbonate hydrates
    Patent number: 5968976
    Abstract: Selected lanthanum carbonate hydrates may be administered into the gastrointestinal tract, to treat hyperphosphataemia in patients with renal failure.
    Type: Grant
    Filed: January 2, 1998
    Date of Patent: October 19, 1999
    Assignee: AnorMed Inc.
    Inventors: Barry A Murrer, Nigel A Powell